EPAS1 and pulmonary arterial hypertension: Supporting these findings, it had been demonstrated that suppressing HIF2α using an inhibitor (PT2567) or HIF2α knockout mice attenuated the cell proliferation processes, development of pulmonary hypertension, and RVH in rats exposed to 5 weeks of hypobaric hypoxia [66].